The global cardiac rhythm management devices market size is expected to touch USD 35.22 billion by 2026 growing at a CAGR of 7.5% from 2019 to 2026, Cardiac rhythm management devices have witnessed evolution of pacemakers, cardiac resynchronization therapy, implantable cardioveter defibrillators and loop recorders over the last decade. The growth drivers for the market include favorable legislative policies followed by Government in developed and developing countries. Additional market drivers include rising incidence of cardiovascular diseases (CVD’s), cohesive reimbursement climate and technological advancements that boost market growth
CRM devices are the universal
solution for patients suffering from arrhythmias. Latest findings in Cardiac
Resynchronization therapy devices are anticipated to drive this market.
Furthermore, implantable cardioverter-defibrillators have opened up more vistas
of operations since their integration with pacemakers. This increases the
product life for pacemakers. Cardioverter- defibrillators having found immense
applications are certain to expand market growth.
Get Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/cardiac-rhythm-management-devices-market/request-for-sample
Sudden Cardiac Arrest (SCA) is
also debilitating human population that explains high growth of external
defibrillators. Government initiatives are working in the direction of making
economies more cardio-friendly. This works positively for external
debrifillators to experience surging market growth.
As per Government data available
More than 6.0 million people have fallen prey to cardiac disorders. Of these,
0.8 million are victims of atrioventricular blockage that ends in cardiac
failure. This proves an outgo of USD 20-60 billion annually. Hence to prevent
this, CRM devices are being put to effective use to prevent surgical costs from
inflating and also prevents readmission charges, thus impacting market growth.
North America took credit of
nearly 35% overall market for CRM Devices in 2016. This was particularly due to
supportive legislative policies, lenient reimbursement schemes and increase in
cardiovascular diseases. Asia Pacific was seen as fast growing market for CRM
devices with a CAGR of 9%. This was largely made possible due to accessibility
of CRM devices.
Do you have
questions or special requirements? Ask our industry experts @ https://www.polarismarketresearch.com/industry-analysis/cardiac-rhythm-management-devices-market/speak-to-analyst
The key players operating in
Cardiac Rhythm Management Devices Implantation include St, Jude Medical,
BIOTRONIK, Inc., Medtronic and Boston Scientific Corporation and ZOLL Medical
Corporation among others.
Polaris
Market Research has segmented the global Cardiac Rhythm Management (CRM) market
on the basis of product and Region:
CRM
Devices Product Outlook (Revenue USD Millions 2015-2026)
- ·
Pacemakers
- ·
Implantable
Pacemakers
- ·
External
pacemakers
- ·
Defibrillators
- ·
Implantable
Cardioverter Defibrillator
- ·
Subcutaneous
ICD
- ·
Transvenous
ICD
- ·
External
Defribillator
- ·
Manual
ED
- ·
Automated
ED
- ·
Wearable
Cardioverter Defibrillator
- ·
Cardiac
Resynchronization Therapy (CRT)
- ·
CRT-
Defibrillators
- ·
CRT-Pacemakers
No comments:
Post a Comment
Please do not enter any spam link in the comment box...